Effect of the type of N-substituent in the benzo-18-azacrown-6 compound on copper(<scp>ii</scp>) chelation: complexation, radiolabeling, stability in vitro, and biodistribution in vivo-Reference-Cited by-同舟云学术

Effect of the type of N-substituent in the benzo-18-azacrown-6 compound on copper(ii) chelation: complexation, radiolabeling, stability in vitro, and biodistribution in vivo

Published:2023 Issue:23 Volume:52 Page:8092-8106
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Zamurueva L. S.¹,Egorova B. V.¹^ORCID,Ikonnikova I. S.¹,Zubenko A. D.²^ORCID,Pashanova A. V.²,Karnoukhova V. A.²,Mitrofanov A. A.¹^ORCID,Trigub A. L.³,Moiseeva A. A.¹,Priselkova A. B.⁴,Fedorova O. A.²^ORCID,Kalmykov S. N.¹

Affiliation:

1. Department of chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia

2. A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, 119991 Vavilova, 28, GSP-1, Moscow, Russian Federation

3. National Research Center “Kurchatov Institute”, 123098 Akademika Kurchatova sqr., 1, Moscow, Russian Federation

4. Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, Leninskie Gory, 1, 119991 Moscow, Russia

Abstract

In this work, we synthesized two new benzo-18-azacrown-6 ethers bearing picolinate and pyridine pendant arms and studied the copper complexes of these ligands, as well as those of an acetate analog.

Funder

Ministry of Science and Higher Education of the Russian Federation

Russian Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/DT/D3DT00742A

Reference60 articles.

1. Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals

2. Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease

3. Cationic radionuclides and ligands for targeted therapeutic radiopharmaceuticals

4. clinicaltrials.gov, https://clinicaltrials.gov

5. Aromatic and heteroaromatic azacrown compounds: advantages and disadvantages of rigid macrocyclic ligands